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Abstract
Background: We previously demonstrated nociceptive discharges to be evoked by mechanical noxious stimulation
in the prefrontal cortex (PFC). The nociceptive responses recorded in the PFC are conceivably involved in the
affective rather than the sensory-discriminative dimension of pain. The PFC receives dense projection from the
limbic system. Monosynaptic projections from the basolateral nucleus of the amygdala (BLA) to the PFC are known
to produce long-lasting synaptic plasticity. We examined effects of high frequency stimulation (HFS) delivered to
the BLA on nociceptive responses in the rat PFC.
Results: HFS induced long lasting suppression (LLS) of the specific high threshold responses of nociceptive
neurons in the PFC. Microinjection of N-methyl-D-aspartic acid (NMDA) receptor antagonists (2-amino-5-
phosphonovaleric acid (APV), dizocilpine (MK-801)) and also metabotropic glutamate receptor (mGluR) group
antagonists (a-methyl-4-carboxyphenylglycine (MCPG), and 2-[(1S,2S)-2-carboxycyclopropyl]-3-(9H-xanthen-9-yl)-D-
alanine (LY341495)), prevented the induction of LLS of nociceptive responses. We also examined modulatory
effects of dopamine (DA) on the LLS of nociceptive responses. With depletion of DA in response to 6-
hydroxydopamine (6-OHDA) injection into the ipsilateral forebrain bundle, LLS of nociceptive responses was
decreased, while nociceptive responses were normally evoked. Antagonists of DA receptor subtypes D2 (sulpiride)
and D4 (3-{[4-(4-chlorophenyl) piperazin-1-yl] methyl}-1H-pyrrolo [2, 3-b] pyridine (L-745,870)), microinjected into
the PFC, inhibited LLS of nociceptive responses.
Conclusions: Our results indicate that BLA-PFC pathways inhibited PFC nociceptive cell activities and that the DA
system modifies the BLA-PFC regulatory function.
Background
Psychological conditions like attention [1] and hypnotic
effects [2] exert powerful influences on human pain sen-
sation [3]. The anterior cingulate cortex (ACC) is an
area responsible for the affectional dimension of pain
[4]. Noxious stimulation applied to peripheral tissues
evoked nociceptive responses in rodent cingulate areas
[5,6] lesions of which impaired place avoidance test
while pain behavior on formalin test was normal [7].
The PFC has crucial roles in conscious pain but not the
sensory-discriminative aspect of pain. The psychological
modulatory influence on pain response in the PFC
could be related to dense projections from the limbic
areas [8,9]. Influences of direct projections from the
amygdala to the PFC on neural activities have been less
investigated electrophysiologically. We analyzed how the
projections alter the PFC neural discharges evoked by
noxious stimulation.
Neurons of the BLA project directly to the PFC [10],
and terminate in layers II and V of the PFC [11]. These
projecting neurons from the BLA, forming monosynap-
tic connections to PFC neurons, are glutamate immuno-
positive [12]. BLA-PFC projections using glutamate as a
neurotransmitter have the potential to induce plastic
changes in cortical synapses. In fact, HFS delivered to
the amygdala induced long-term potentiation of field
potentials in the PFC [13]. Electrophysiological studies
* Correspondence: blackcat@research.twmu.ac.jp
† Contributed equally
2Department of Physiology, School of Medicine, Tokyo Women’s Medical
University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
Full list of author information is available at the end of the article
Onozawa et al. BMC Neuroscience 2011, 12:115
http://www.biomedcentral.com/1471-2202/12/115
© 2011 Onozawa et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.employing PFC slices showed HFS to induce long-term
depression (LTD) [14]. BLA-PFC pathways may thus
change long-lasting neuronal activities of PFC neurons.
DA, which is considered to regulate attention in the
PFC [15], acts as a modulator and induces bidirectional
excitatory or inhibitory effects on PFC neurons [16]. DA
also modifies plastic changes in PFC neurons of superfi-
cial layers [17]. Microinjections of DA into the ACC
reduced autotomy scores in a sciatic neurotomy model,
indicating DA in the PFC to block long-term nocicep-
tive responses [18]. DA in the PFC may thus modulate
pain processing.
Our experiments elucidated that the BLA-PFC projec-
tions and the mesocortical DA system affected dis-
charges of PFC neurons elicited by noxious stimulation.
The BLA-PFC pathways, and influences of the DA sys-
tem on these pathways, may underlie psychological
states mediating pain sensations.
Results
Nociceptive responses recorded in the PFC
Mechanical stimulation induced excitatory responses in
PFC neurons, with discharges of a specific high threshold
type which persisted during and frequently after stimula-
tion [6]. The spontaneous background discharges of
these neurons usually showed the spindle bursts charac-
teristic of urethane anesthesia. Electrocorticograms
(ECoG) changed from slow waves with spindle bursts to
low amplitude fast waves induced by mechanical stimula-
tion (Figure 1A). The nociceptive responses were
recorded without adaptation, if mechanical stimulation
was applied every 90 s. We also recorded electroencepha-
lographic (EEG) data in the amygdala, which showed
changes in responses to mechanical simulation similar to
those in the PFC (Figure 1A).
HFS delivered to the BLA modified pain responses
recorded in the PFC
HFS delivered to the BLA impaired PFC nociceptive
responses evoked by mechanical stimulation applied to
the rat tail (Figure 2A, n = 9, 9 units/9 rats). LLS of noci-
ceptive responses appeared within 10 min and lasted
more than 60 min after HFS. Decreases in responses
were to 23.6 ± 15.5% of the pre-HFS control level at 10
min (p < 0.05), 13.5 ± 8.9% at 30 min (p < 0.01), 40.8 ±
16.6% at 60 min (p < 0.05) and 85.3 ± 3.7% at 90 min (p
= 0.11) (Figure 2B). The mean discharge frequency of
responses also decreased after HFS in the same manner
as response duration (Figure 2C, p < 0.001). Therefore,
we used discharge duration to represent nociceptive
responses in this study. Nociceptive responses recovered
to pre-HFS levels in approximately 90-120 min. Microin-
jection of artificial cerebr o s p i n a lf l u i d( A C S F )h a dn o
effects on control nociceptive responses in the PFC (n =
5, 5 units/5 rats). HFS delivered to the BLA clearly inhib-
ited nociceptive responses in rats injected with ACSF. At
10 and 30min after HFS, nociceptive responses were sig-
nificantly suppressed. In the intact group nociceptive
responses had not recovered to the pre-stimulus level at
60 min (Figure 2B, C). In contrast, the ACSF group
responses recovered to 75.6 ± 25.0% of the pre-HFS level
(P = 0.5).
NMDA receptor blockers impaired LLS of nociceptive
responses
NMDA receptor blockers impaired effects of HFS on
nociceptive responses. MK-801, which had no effects on
control nociceptive responses, completely inhibited the
LLS of nociceptive responses induced by HFS delivered
to the BLA (n = 5, 5 units/5 rats). Rates of changes in
nociceptive responses were 112.6 ± 11.5% of the pre-HFS
value at 10 min (p = 0.27), 132.0 ± 17.8% at 30 min (p =
0.14) and 109.6 ± 10.1% at 60 min (P = 0.35) (Figure 3A,
B). As with MK-801, microinjection of APV also reduced
the effects of HFS on nociceptive responses (n = 5,
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Figure 1 A typical example of nociceptive discharges evoked by
peripheral mechanical stimulation. A. The top trace represents an
ECoG. The second trace is multiple unit discharges evoked by
mechanical stimulation. The third trace is an EEG recorded via
stimulating electrodes in the BLA. Nociceptive stimulation also
induced EEG changes. The bottom trace represents a pressure curve.
B. Durations of responses and post-stimulus discharges (PSD) are
shown as a histogram. One bin is 500 msec. Vertical lines represent
the stimulus starting point and the horizontal broken line represents
the mean level of spontaneous discharges.
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differences in rates of changes versus the control value;
92.1 ± 2.8% at 10 min (p = 0.08), 92.8 ± 7.0% at 30 min
(p = 0.35) and 105.3 ± 5.0% at 60 min (p = 0.29).
Metabotropic glutamate receptor blocker
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impaired LLS of nociceptive responses induced by HFS
delivered to the BLA (n = 5, 5 units/5 rats). Durations
of nociceptive responses did not differ significantly from
the control level at 10 min (p = 0.50, 116.8 ± 19.8%), or
at 60 min (104.8 ±10.1%, p = 0.08). Inhibitory effects
were, in fact, observed only at 30 min after HFS (83.1 ±
6.8%, versus pre-HFS control level, p < 0.05) (Figure 3C,
D). However, the nociceptive response at 30 min was
significantly longer than that of the ACSF group (0%,
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Figure 2 HFS delivered to the BLA suppressed nociceptive responses recorded in the PFC. On the left, unit discharges: on the right, the
histogram of single unit discharges calculated from the unit discharge. A. Unit discharges recorded in the PFC. Pre: Nociceptive responses evoked by
500 gf stimulation applied to the rat tail. At 50 min after HFS delivery to the BLA, the nociceptive responses were entirely blocked. At 90 min after HFS,
nociceptive responses had recovered to the pre-HFS control level. B. Inhibitory effects of nociceptive responses were induced by HFS delivered to the
BLA. The inhibitory effects of nociceptive responses appeared within 10 min and lasted longer than 60 min after HFS. The duration of the control
nociceptive responses was assessed as 100% and changes in duration after HFS to the BLA were converted into percentages of the control value. n =
9. *p < 0.05, versus the pre-HFS control value, **p < 0.001, versus the pre-HFS control value. Error bars represent S.E. C. The mean discharge frequency
of the control nociceptive responses was assessed as 100% and changes in mean discharge frequency after HFS to the BLA were converted into
percentages of this control value. *p < 0.05, versus the pre-HFS control value, **p < 0.001, versus the pre-HFS control value. Error bars represent S.E.
Mean discharge frequency of nociceptive responses also decreased after HFS in the same manner as the response duration. The statistical significance
of differences between results obtained by the two methods was calculated using ANOVA. There were no significant differences between the mean
discharge frequency of responses changes (n = 9) and response duration changes (n = 9).
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Page 3 of 10p < 0.05). A selective antagonist of group II mGluR,
LY341495, completely blocked LLS of nociceptive
responses induced by HFS (n = 7, 7 units/6 rats). Dura-
tions of pain responses were 94.4 ± 11.4% at 10 min (p
= 0.24), 92.4 ±11.6% at 30 min (p = 0.61) and 85.3 ±
8.4% at 60 min (p = 0.09) (Figure 3D).
DA depletion impaired LLS of nociceptive responses
DA depletion was established by apomorphine tests three
weeks after 6-OHDA injection into the medial forebrain
bundle (MFB, n = 8, 8 units/8 rats). In apomorphine test-
positive animals, background ECoG showed low voltage
fast waves, as described in a previous report [19].
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Figure 3 A glutamate receptor blocker blunted the inhibitory effects of nociceptive responses induced by HFS. A.P r e :S m a l l e ru n i t
discharges in response to mechanical stimulation. The second trace represents single unit responses selected by cluster analysis from multiple
units in the top line. At 30 min after HFS, microinjection of MK-801 completely inhibited LLS of nociceptive responses. B. NMDA antagonists, APV
and MK-801, suppressed the effects of HFS on nociceptive responses. The duration of control nociceptive responses was assessed as 100% and
changes in duration after HFS to the BLA were converted into percentages of the control value. There were no significant changes from the pre-
HFS control value. In the ACSF group, nociceptive responses were completely blocked at 10 and 30 min after HFS but had recovered to the pre-
HFS control value by 60 min. *p < 0.05, versus the pre-HFS control value. Error bars represent S.E. n = 15. C. After microinjection of MCPG (an
mGluR group I and II antagonist) into the PFC, unit discharges were recorded in the PFC. Pre: prior to HFS delivery to the BLA. Multiple unit
discharges responded to peripheral noxious stimulation. At 30 min after HFS, microinjection of MCPG blocked induction of LLS of nociceptive
responses. D. Effects of mGluR antagonists on LLS of nociceptive response. MCPG partially blocked LLS of nociceptive responses induced by HFS
to the BLA. Inhibitory effects were observed only at 30 min after HFS. An mGluR group II antagonist, LY341495, completely blocked LLS of
nociceptive responses. *p < 0.05, versus the pre-HFS control value. Error bars represent S.E. n = 12.
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Page 4 of 10However, nociceptive responses were normally evoked by
mechanical stimulation delivered to the tail. There was no
difference in mean nociceptive responses (p = 0.15)
between the control and 6-OHDA groups (4.6 s and 3.6 s,
respectively). HFS applied to the BLA had no effects on
the nociceptive responses in this group (Figure 4A). Rates
of changes in nociceptive responses were 139.3 ± 21.8% at
10 min (p = 0.12), 132.7 ± 22.5% at 30 min (p = 0.16) and
126.7 ± 27.7% at 60 min (p = 0.26) after HFS (Figure 4B).
The duration of nociceptive responses tended to increase
in DA-depleted animals, but the difference versus the pre-
HFS control value did not reach statistical significance.
DA receptor subtype antagonists
A D2 receptor antagonist, sulpiride (n = 5, 5 units/4 rats),
was also injected into the PFC. Sulpiride significantly
blocked the inhibitory effects of HFS to the BLA (Figure
5A, B). Durations of pain responses were 116.8 ± 9.4% at
10 min (p = 0.14), 111.8 ± 8.9% at 30 min (p = 0.47) and
110.4 ±1 3.1% at 60 min (p = 0.69) after HFS to the BLA.
In the sulpiride-treated group, the durations of pain
responses tended to be increased but did not differ signif-
icantly from the pre-HFS control value (Figure 5B).
A specific D4 receptor antagonist, L-745, 870 (n = 14,
14 units/8 rats), also significantly blocked the LLS of
nociceptive responses induced by HFS without changes
in either nociceptive responses or background ECoG.
Durations of pain responses were 104.3 ± 11.5% at 10
min (p = 0.73, versus pre HFS value), 80.9 ± 16.27% at
30 min (p = 0.27) and 106.4 ± 13.1% at 60 min (p =
0.55) after HFS to the BLA (Figure 5B). These results
indicate that L-745,870 blocks LLS of nociceptive
responses evoked by HFS applied to the BLA.
Discussion
We previously recorded nociceptive responses in layer II
and also found Fos expression to be induced by
mechanical noxious stimulation in surface layers of the
PFC [6]. Monosynaptic projections from the BLA also
terminated in layer II of the PFC [11]. Assuming that
nociceptive information from peripheral nociceptors and
inputs from the BLA integrate at the same pyramidal
cells in layer II of the PFC, HFS delivered to BLA-PFC
may induce heterosynaptic plasticity. Heterosynaptic-
LTD, which has been demonstrated in perforant path
synapses of the hippocampus [20,21], is reportedly
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Figure 4 DA depletion impaired the inhibitory effects of nociceptive responses induced by HFS. A. Nociceptive discharges were recorded
in the PFC of the side ipsilateral to 6-OHDA injection. Pre: Nociceptive responses were normally evoked by mechanical stimulation delivered to
the rat tail. At 60 min after HFS delivery to the BLA, there were no apparent effects on nociceptive responses. DA depletion completely blocked
LLS of nociceptive responses induced by HFS. B. The duration of nociceptive responses tended to increase in this group, but the difference from
the pre-HFS control value did not reach statistical significance. Error bars represent S.E. n = 8 The control figure is same as figure 2 B. *p < 0.05,
**p < 0.001, versus the pre-HFS control value.
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Page 5 of 10blocked by NMDA receptor blockers [22]. In our experi-
ments, APV and MK-801 impaired LLS of nociceptive
responses. NMDA receptor activities were required for
the induction of LLS of nociceptive responses, suggest-
ing heterosynaptic-LTD like mechanisms to underlie
these responses. Brief application of Group I and II
mGluR agonists [23] or co-activation of mGluR II and
NMDA receptors reportedly induces LTD in pyramidal
neurons [24]. Depolarization of postsynaptic cells is
indispensable for mGluR mediated heterosynaptic-LTD
[25]. In our experiments, glutamate release via ascending
pathways relying sensory information and NMDA acti-
vation by HFS delivered to the BLA produced LLS of
nociceptive responses in the PFC characterizing the
responses as LTD.
The DA system has been assumed to modulate PFC
plasticity [26]. Co-application of DA and the mGluR
agonist without tetanic stimulation induced LTD in PFC
pyramidal neurons [27]. DA does not directly mediate
synaptic transmission but affects it by altering the
synaptic properties of target neurons [15]. A behavioral
study of pain demonstrated that DA depletion induces
significant changes in thresholds for mechanical noxious
stimuli [28]. Partial DA depletion in our experiments
had no effects on nociceptive responses themselves but
blocked plastic changes in nociceptive responses. DA
application produces only a small membrane depolariza-
tion (2-3 mV) in pyramidal cells [29] but affects spike
afterpotentials [30] which consist of after-hyperpolariza-
tion or depolarization. Partial depletion of DA may inhi-
bit slow after-depolarization followed by LLS induction,
while having little effect on the initiation of action
potentials [31]. Emotional influences of inputs from the
BLA on PFC nociceptive responses might be modulated
by DA.
A D2 receptor antagonist, sulpiride, blocked LLS of
nociceptive responses in the PFC. Postsynaptic D2 recep-
tor activities reduce membrane depolarization evoked by
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
agonist application [15]. Moreover, D2 receptor knockout
mice showed impaired LTD induction in response to
tetanic stimulation delivered to cortico-striatal pathways
[32]. In addition to postsynaptic D2 receptor inhibitory
effects, presynaptic D2 receptors showed impaired gluta-
mate release in the ventral tegmental area [33]. D2
antagonists may affect both pre- and post-synaptic recep-
tors and thereby block the induction of LLS of nocicep-
tive responses. D4 receptors, which are highly expressed
in PFC pyramidal cells [34], inhibit adenylate cyclase
through Gi/o-proteins by functioning as D2-like recep-
tors [35]. Electrophysiological experiments using current
and voltage clamp methods demonstrated spontaneous
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Figure 5 DA receptor subtypes modified LLS of nociceptive responses induced by HFS. A. Pre: A typical case with sulpiride injection is
shown. Nociceptive responses were normally evoked by mechanical stimulation delivered to the rat tail after microinjection of sulpiride (upper
trace). At 30 min after HFS, a D2 receptor antagonist completely blocked LLS of nociceptive responses induced by HFS to the BLA (lower trace).
B. D2 and D4 receptor antagonists suppressed the induction of LLS of nociceptive responses by HFS. Error bars represent S.E. n = 19. The
control figure is same as figure 3 B, C. *p < 0.05, **p < 0.001, versus the pre-HFS control value.
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Page 6 of 10hyper-excitability of pyramidal neurons in a D4 receptor
knockout mouse model [36]. Hence, D4 receptors nor-
mally exert an inhibitory influence on the activities of
pyramidal neurons. D4 receptor activities may facilitate
induction of LLS of nociceptive responses by HFS deliv-
ered to the BLA.
According to human brain image analysis, the strength
of conscious pain reflects activities of the ACC [2,37,38].
BLA-PFC projections may transmit aversive information
from the limbic area to the PFC, which is involved in
psychological states of dependent pain sensation like
fear conditioning analgesia. BLA-PFC pathways are
reportedly involved in fear expression and extinction
[39]. NMDA activation in the BLA and PFC are
required for relearning of inhibitory fear responses in
extinction [40]. Our LLS results suggest that impulses
from the BLA depressed nociceptive responses, as a
consequence, pain recognition in the PFC was inhibited
in fear responses.
The mesocortical DA system from the ventral tegmental
area to the PFC plays roles in psychological conditions
such as attention and motivation. Our results indicate that
amygdala inputs to the PFC influence pain sensations via
emotional stimulation and that the DA system exerts
modulatory effects on conscious pain processing.
Conclusions
Mechanical noxious stimulation applied to peripheral
tissue evoked nociceptive discharges in the PFC. HFS
delivered to the BLA inhibited nociceptive responses,
which are involved in the mGluR-mediated LTD-like
mechanism. This inhibition was impaired by DA recep-
tor subtype (D2 and D4) blockers. BLA-PFC projections
influence pain responses and the DA system exerts
modulatory effects on pain responses recorded in the
PFC. Inputs from the BLA and DA system to the PFC
may be responsible for conscious pain.
Methods
Animal preparation
Male Wistar rats (300-400 g; Sankyo Laboratory Co.,
Tokyo, Japan) were used in all experiments. The rats
were housed under controlled temperature (25°C) and
humidity (40-45%) conditions with a 12-h light/dark
cycle, and had free access to food and water. Experi-
ments conformed to the guidelines issued by the
National Institutes of Health for Laboratory Animals.
All procedures were performed in accordance with the
guidelines for animal care of the Animal Experiments
Committee of Tokyo Women’s Medical University and
have been approved by Ethical Review Committee of
Animal Experiments Tokyo Women’s Medical Univer-
sity (Serial No.021). Efforts were made to minimize the
number of animals used and their suffering.
Recording and Stimulating electrodes
All animals were anesthetized with urethane (1.0-1.2 g/
kg, i.p) and placed in a stereotaxic frame (Narishige,
Tokyo, Japan). Tungsten microelectrodes (Frederick
Haer & Co., Bowdon, ME, USA) with an impedance of
9-12 MΩ implanted in the BLA as stimulus electrodes
were also used as recording electrodes. HFS (100 Hz,
+20 μA for 30 s) was delivered to the BLA. We recorded
extracellular unit discharges and local field ECoG from a
typical nociceptive specific neuron through the same
recording electrode [6]. The unit spikes were processed
with a multichannel amplifier (MEG-6100; 0.08-3000
Hz; Nihon Kohden Co., Tokyo, Japan) and an active fil-
ter (DV-04; 500-3000 Hz; NF Electronic Instruments
Co., Yokohama, Japan). Through a memory oscilloscope
(VC-11; Nihon Kohden), the data were fed into a ther-
mal array recorder (Nihon-Kohden) for paper recording
and a personal computer (Macintosh G4; Apple Co.,
Tokyo, Japan) via an integrated system (PowerLab/4SP;
Mountain View, CA, USA) for recording storage and
later off-line analysis. In all animals, the recording elec-
trodes were positioned in the medial PFC (mPFC, coor-
dinates in mm: 2.7-3.7 anterior and 0.1-0.5 lateral to the
bregma) (Figure 6A). As shown in Figure 6B, the


Bregma -3.24 mm  -3.36 mm
Bregma 2.76 mm 3.00 mm 3.24 mm 3.72 mm A)
B)
Figure 6 Areas of mPFC recording and BLA stimulation. A.
Recording points of unit discharges. The solid squares represent
actual recording points. All unit discharges are scattered throughout
surface layers of the cingulate and prelimbic areas. The numbers
above represent distance from the bregma. B. In the BLA, the solid
squares represent stimulus points. The numbers represent distance
from the bregma.
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Page 7 of 10stimulating electrodes were positioned in the BLA
(coordinates in mm: 3.2-3.4 posterior and 4.4-4.5 lateral
to the bregma, 7.75-7.8 ventrally below the dura).
Mechanical stimulation
We applied mechanical pressure to the tail, at 1.0-4.0 cm
distal to the body, via a mechanical stimulator (DPS-270;
DIA Medical System Co., Tokyo, Japan), using a probe
with a circular contact area with a 1 mm in diameter tip.
Mechanical stimuli were delivered every 90 s at constant
force with a feedback system. Stimulus intensities used in
this experiment were 500 gf with a 0.1 s rising time to
maximum force and a 2 s hold time. Previous studies
showed a nociceptive stimulus intensity of 300 gf to be
sufficient to induce C-fiber mediated activity in peripheral
nerves [41]. We employed a typical nociceptive specific
neuron, which responded only to a stimulus intensity
exceeding 300gf [6].
Drugs and injection techniques
In the drug injection experiments, we used recording
electrodes with a Teflon microtube (TF205-074, Unique
Medical Co., Japan). Each drug was injected into the
mPFC using a microinjector (55-1111, Harvard Appara-
tus Co., Miami, FL, USA). Extracellular unit discharges
and local ECoG were recorded for at least 15 min before
and after the injection to ensure that the drug injections
had no effects on nociceptive responses in the PFC. We
also injected ACSF (4 μl, pH = 7.4) alone at a rate of
20 μl/hr as a control.
Drugs used in the extracellular unit recording were
MK-801 (1.0 μg/4 μl, NMDA receptor antagonist; Sigma,
S t .L o u i s ,M O ,U S A )[ 4 2 ] ,A P V( 2 0n g / 1 0μl, NMDA
receptor antagonist; Sigma) [43], MCPG (1.0 μg/3.5 μl,
mGluR group I and II antagonist; Sigma) [44], LY341495
(0.4 μg/3.2 μl, mGluR group II antagonist; Tocris Cook-
son, Ellisville, MO, USA) [45], sulpiride (17 ng/5 μl, DA
D2 receptor antagonist; Sigma) [46] and L-745,870
(0.4 μg/2 μl, DA D4 receptor antagonist; Sigma) [47] at a
rate of 20 μl/hr. These drugs were dissolved in ACSF
alone.
Data analysis
A single unit spike was discriminated on the basis of the
height and width of each unit from a multiple unit
recording by applying cluster analysis methods with the
software program “Chart and Spike Histogram” (AD
Instruments Co., Tokyo, Japan). Each bin of histograms
consisted of spikes during a 500 ms period. The duration
of the responses and discharge frequency both reflect sti-
mulus intensity [6]. Thereby, we measured both duration
and mean discharge frequency as responses evoked by
mechanical stimulation. The durations of evoked tonic
discharges exceeding mean spontaneous discharges on
the histogram were assessed as the responses durations
(Figure 1B). The mean value of three successive nocicep-
tive responses just before HFS was assessed as 100% i.e.
as the control. We recorded ECoG and spontaneous dis-
charge as baseline data for 10 s before applying mechani-
cal pressure to the tail. Spontaneous mean discharge
frequency and ECoG did not change after as compared
to before mechanical stimulation and HFS. However, we
waited for recovery until the same ECoG pattern or
administered additional anesthesia to maintain the same
ECoG pattern.
Unilateral injection of 6-OHDA
Rats were anesthetized with Nembutal (50 mg/kg i.p).
Then, 5 μl of 6-OHDA HCl (2 mg in 1ml of saline con-
taining 0.1% ascorbic acid; Sigma) were injected into the
left MFB (coordinates in mm: 4.5 posterior and 1.1 lateral
to the bregma, 8.2 ventrally below the dura) through a
cannula with a microinjection pump at a rate of 20 μl/hr,
and the cannula was left in place for 10 min after the
completion of pumping. At the end of the injection, the
skin was sutured. We assessed motor disturbances 3
weeks after 6-OHDA treatments by observing full-rota-
tions in a cylindrical container (40 cm diameter, LE 902/
Rp Container; Panlabs.I., Barcelona, Spain) for 30 min
after apomorphine (1 mg/kg i.p.) administration. The
same experimental procedures as described above
(Recording and Stimulating electrodes) were carried out
after DA depletion had been established. Nociceptive dis-
charges were recorded in the PFC ipsilateral to the 6-
OHDA injection. As a control, no apomorphine-induced
rotational asymmetry was observed in the intact group.
Statistical analysis
The significance of differences in discharges evoked by
mechanical stimuli was assessed with the nonparametric
paired-test (Wilcoxon) to compare pre- and post-HFS
values (Stat View-J5.0; SAS Institute Inc., Berkeley, CA,
USA). Differences in nociceptive responses between the
drug-injected groups and the ACSF-injected group were
statistically analyzed with repeated measure analysis of var-
iance (ANOVA). Data are expressed as means ± standard
errors (S.E.). A probability level <0.05 was considered
significant.
Histological site of unit recordings
The locations of units were marked with a positive electric
current lesion (direct current, +80 μA for 15 s). At the end
of each experiment, the animals were perfused with nor-
mal saline and 4% paraformaldehyde. The brains were
removed, sectioned (50 μm) and then stained with hema-
toxylin-eosin solution to examine the recording sites
Onozawa et al. BMC Neuroscience 2011, 12:115
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located in the cingulate or the prelimbic area, were used
for data analysis.
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